Tessari Eben's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed Sep 8, 2025
- Accession no.
- 0001415889-25-023878
- Filed
- Sep 8, 2025
- Trade date
- Sep 4-5, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.51M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tessari EbenCIK 0001867899 | Officer (CHIEF OPERATING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +38,725 | $15.50 | +$600,237.5 | 83,177 | Direct | |
| Sep 4, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +46,546 | $15.52 | +$722,393.92 | 129,723 | Direct | |
| Sep 4, 2025 | Class A Ordinary Share | SSaleDisposed | −85,271 | $35.52 | −$3,028,825.92 | 44,452 | Direct | |
| Sep 5, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +13,389 | $15.52 | +$207,797.28 | 57,841 | Direct | |
| Sep 5, 2025 | Class A Ordinary Share | SSaleDisposed | −13,389 | $35.66 | −$477,451.74 | 44,452 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −38,725 | $0.00 | $0 | 6,249 | Direct | |
| Sep 4, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −46,546 | $0.00 | $0 | 13,389 | Direct | |
| Sep 5, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −13,389 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.